Dow Up 0.51% Nasdaq Up 0.13%

Aerie Pharmaceuticals, Inc. (AERI)

-NasdaqGM
16.82 Down 0.69(3.94%) 3:28PM EDT - Nasdaq Real Time Price
Prev Close:17.51
Open:17.45
Bid:16.75 x 400
Ask:16.82 x 200
1y Target Est:37.75
Beta:N/A
Next Earnings Date:N/A
Day's Range:16.67 - 17.54
52wk Range:10.25 - 29.71
Volume:61,176
Avg Vol (3m):351,392
Market Cap:401.81M
P/E (ttm):N/A
EPS (ttm):-3.23
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AERI

Comparison

Symbol% ChgMkt Cap
AERIDown 3.94%401.81M
AKRXDown 0.21%3.91B
IRIXUp 3.10%78.90M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.44
Quarterly EPS Est (Sep-14) :-0.41
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, is focused on the discovery, development, and commercialization of first-in-class glaucoma therapies. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback